Entry Point Capital, LLC Standard Biotools Inc. Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 113,867 shares of LAB stock, worth $216,347. This represents 0.13% of its overall portfolio holdings.
Number of Shares
113,867Holding current value
$216,347% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
142Shares Held
279MCall Options Held
27.2KPut Options Held
34.1K-
Casdin Capital, LLC New York, NY71.3MShares$135 Million10.68% of portfolio
-
Viking Global Investors LP58.7MShares$111 Million0.44% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$41.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$32.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY15.2MShares$29 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $149M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...